Numenos

New York, NY · Founded 2023 · Privately Held (backing)

Developer of an artificial intelligence clinical trial development platform designed to uncover new biology and biomarkers that predict patient response. Numenos is based in New York, NY and was founded in 2023. Its last reported valuation was $21.8 million in Jan 2025. It has raised $7.7 million.

Last reported valuation
$21.8M
Oct 2026
Priced at
—
Total raised
$7.7M
Last round
—

Who backs Numenos?

3 investors
InvestorType
Dhuna VenturesVenture capital
Meron Capital—
TechAviv Founder Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Numenos investors

3 investors are on record for Numenos, including Dhuna Ventures, Meron Capital and TechAviv Founder Partners.

Free account
More of Numenos with a free account
  • ·Watch Numenos: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 3 firms already write checks for companies like Numenos. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View